nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—CYP2C9—brain cancer	0.855	1	CbGaD
Glimepiride—Paresis—Temozolomide—brain cancer	0.00267	0.0216	CcSEcCtD
Glimepiride—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00212	0.0172	CcSEcCtD
Glimepiride—Disorder sight—Temozolomide—brain cancer	0.00204	0.0166	CcSEcCtD
Glimepiride—Eruption—Hydroxyurea—brain cancer	0.00202	0.0164	CcSEcCtD
Glimepiride—Gliclazide—VEGFA—brain cancer	0.00175	0.239	CrCbGaD
Glimepiride—Nocturia—Procarbazine—brain cancer	0.00173	0.0141	CcSEcCtD
Glimepiride—Cerebration impaired—Temozolomide—brain cancer	0.00165	0.0134	CcSEcCtD
Glimepiride—KCNJ1—telencephalon—brain cancer	0.0016	0.111	CbGeAlD
Glimepiride—Aphasia—Carmustine—brain cancer	0.00155	0.0126	CcSEcCtD
Glimepiride—Pancytopenia—Lomustine—brain cancer	0.00151	0.0122	CcSEcCtD
Glimepiride—Aphasia—Temozolomide—brain cancer	0.0015	0.0122	CcSEcCtD
Glimepiride—Coma—Procarbazine—brain cancer	0.00147	0.0119	CcSEcCtD
Glimepiride—Glipizide—CYP2C9—brain cancer	0.00144	0.198	CrCbGaD
Glimepiride—Gliclazide—CYP2C9—brain cancer	0.00134	0.184	CrCbGaD
Glimepiride—Hepatic function abnormal—Procarbazine—brain cancer	0.00134	0.0108	CcSEcCtD
Glimepiride—Haemolytic anaemia—Procarbazine—brain cancer	0.00129	0.0105	CcSEcCtD
Glimepiride—Cholestasis—Temozolomide—brain cancer	0.00128	0.0104	CcSEcCtD
Glimepiride—Visual impairment—Lomustine—brain cancer	0.00123	0.00995	CcSEcCtD
Glimepiride—Speech disorder—Carmustine—brain cancer	0.00117	0.00949	CcSEcCtD
Glimepiride—Accidental injury—Carmustine—brain cancer	0.00114	0.00923	CcSEcCtD
Glimepiride—Speech disorder—Temozolomide—brain cancer	0.00113	0.00917	CcSEcCtD
Glimepiride—Disturbance in attention—Temozolomide—brain cancer	0.00112	0.00911	CcSEcCtD
Glimepiride—Hyperbilirubinaemia—Temozolomide—brain cancer	0.00107	0.00868	CcSEcCtD
Glimepiride—Chlorpropamide—CYP2C9—brain cancer	0.00104	0.143	CrCbGaD
Glimepiride—Tolbutamide—CYP2C9—brain cancer	0.00102	0.139	CrCbGaD
Glimepiride—ABCC8—brainstem—brain cancer	0.00101	0.0702	CbGeAlD
Glimepiride—Hepatic failure—Hydroxyurea—brain cancer	0.00101	0.00816	CcSEcCtD
Glimepiride—Eosinophilia—Procarbazine—brain cancer	0.000999	0.00811	CcSEcCtD
Glimepiride—KCNJ1—head—brain cancer	0.000995	0.0694	CbGeAlD
Glimepiride—Leukopenia—Lomustine—brain cancer	0.000992	0.00804	CcSEcCtD
Glimepiride—Sweating increased—Procarbazine—brain cancer	0.000983	0.00798	CcSEcCtD
Glimepiride—Angina pectoris—Procarbazine—brain cancer	0.000983	0.00798	CcSEcCtD
Glimepiride—Pancytopenia—Procarbazine—brain cancer	0.000959	0.00778	CcSEcCtD
Glimepiride—Dermatitis bullous—Hydroxyurea—brain cancer	0.000946	0.00767	CcSEcCtD
Glimepiride—Pollakiuria—Procarbazine—brain cancer	0.000933	0.00756	CcSEcCtD
Glimepiride—Photosensitivity reaction—Procarbazine—brain cancer	0.000921	0.00747	CcSEcCtD
Glimepiride—Coma—Carmustine—brain cancer	0.00092	0.00746	CcSEcCtD
Glimepiride—Aplastic anaemia—Temozolomide—brain cancer	0.000913	0.00741	CcSEcCtD
Glimepiride—KCNJ1—central nervous system—brain cancer	0.000909	0.0634	CbGeAlD
Glimepiride—Drowsiness—Procarbazine—brain cancer	0.0009	0.0073	CcSEcCtD
Glimepiride—ABCC8—telencephalon—brain cancer	0.000893	0.0623	CbGeAlD
Glimepiride—Thrombocytopenia—Lomustine—brain cancer	0.000885	0.00718	CcSEcCtD
Glimepiride—Jaundice—Procarbazine—brain cancer	0.000877	0.00712	CcSEcCtD
Glimepiride—Mental disability—Carmustine—brain cancer	0.000874	0.00709	CcSEcCtD
Glimepiride—Sweating—Procarbazine—brain cancer	0.000863	0.007	CcSEcCtD
Glimepiride—Anorexia—Lomustine—brain cancer	0.000862	0.00699	CcSEcCtD
Glimepiride—Mental disability—Temozolomide—brain cancer	0.000844	0.00685	CcSEcCtD
Glimepiride—Diabetes mellitus—Carmustine—brain cancer	0.00084	0.00681	CcSEcCtD
Glimepiride—Injury—Carmustine—brain cancer	0.000795	0.00645	CcSEcCtD
Glimepiride—Decreased appetite—Lomustine—brain cancer	0.000786	0.00638	CcSEcCtD
Glimepiride—Hepatic failure—Temozolomide—brain cancer	0.000786	0.00637	CcSEcCtD
Glimepiride—Hot flush—Temozolomide—brain cancer	0.000755	0.00612	CcSEcCtD
Glimepiride—Menopausal symptoms—Temozolomide—brain cancer	0.000748	0.00607	CcSEcCtD
Glimepiride—Pancytopenia—Hydroxyurea—brain cancer	0.000742	0.00602	CcSEcCtD
Glimepiride—Hyponatraemia—Carmustine—brain cancer	0.000734	0.00595	CcSEcCtD
Glimepiride—ABCC8—pituitary gland—brain cancer	0.000727	0.0507	CbGeAlD
Glimepiride—Arrhythmia—Procarbazine—brain cancer	0.000722	0.00585	CcSEcCtD
Glimepiride—KCNJ1—brain—brain cancer	0.000721	0.0503	CbGeAlD
Glimepiride—Weight increased—Hydroxyurea—brain cancer	0.000711	0.00577	CcSEcCtD
Glimepiride—Glyburide—CYP2C9—brain cancer	0.000705	0.0966	CrCbGaD
Glimepiride—ABCC8—medulla oblongata—brain cancer	0.000702	0.0489	CbGeAlD
Glimepiride—Drowsiness—Hydroxyurea—brain cancer	0.000697	0.00565	CcSEcCtD
Glimepiride—Tension—Procarbazine—brain cancer	0.00069	0.0056	CcSEcCtD
Glimepiride—Nervousness—Procarbazine—brain cancer	0.000683	0.00554	CcSEcCtD
Glimepiride—Tremor—Procarbazine—brain cancer	0.000659	0.00535	CcSEcCtD
Glimepiride—Anaemia—Procarbazine—brain cancer	0.00065	0.00527	CcSEcCtD
Glimepiride—ABCC8—midbrain—brain cancer	0.000641	0.0447	CbGeAlD
Glimepiride—Leukopenia—Procarbazine—brain cancer	0.00063	0.00511	CcSEcCtD
Glimepiride—ABCC8—spinal cord—brain cancer	0.000626	0.0436	CbGeAlD
Glimepiride—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000623	0.00505	CcSEcCtD
Glimepiride—Loss of consciousness—Procarbazine—brain cancer	0.000618	0.00501	CcSEcCtD
Glimepiride—Abdominal distension—Temozolomide—brain cancer	0.000614	0.00498	CcSEcCtD
Glimepiride—KCNJ11—endocrine gland—brain cancer	0.000612	0.0426	CbGeAlD
Glimepiride—Convulsion—Procarbazine—brain cancer	0.000609	0.00494	CcSEcCtD
Glimepiride—Hypertension—Procarbazine—brain cancer	0.000607	0.00493	CcSEcCtD
Glimepiride—KCNJ11—head—brain cancer	0.000604	0.0421	CbGeAlD
Glimepiride—Pancytopenia—Carmustine—brain cancer	0.0006	0.00486	CcSEcCtD
Glimepiride—Anxiety—Procarbazine—brain cancer	0.000597	0.00484	CcSEcCtD
Glimepiride—Sweating increased—Temozolomide—brain cancer	0.000595	0.00482	CcSEcCtD
Glimepiride—Dry mouth—Procarbazine—brain cancer	0.000586	0.00475	CcSEcCtD
Glimepiride—Pancytopenia—Temozolomide—brain cancer	0.00058	0.0047	CcSEcCtD
Glimepiride—Confusional state—Procarbazine—brain cancer	0.000579	0.00469	CcSEcCtD
Glimepiride—Vomiting—Lomustine—brain cancer	0.000575	0.00466	CcSEcCtD
Glimepiride—Shock—Procarbazine—brain cancer	0.000565	0.00458	CcSEcCtD
Glimepiride—Pollakiuria—Temozolomide—brain cancer	0.000564	0.00457	CcSEcCtD
Glimepiride—ABCC8—endocrine gland—brain cancer	0.000563	0.0393	CbGeAlD
Glimepiride—Thrombocytopenia—Procarbazine—brain cancer	0.000562	0.00456	CcSEcCtD
Glimepiride—Tachycardia—Procarbazine—brain cancer	0.00056	0.00454	CcSEcCtD
Glimepiride—Photosensitivity reaction—Temozolomide—brain cancer	0.000557	0.00452	CcSEcCtD
Glimepiride—ABCC8—head—brain cancer	0.000556	0.0388	CbGeAlD
Glimepiride—Weight increased—Temozolomide—brain cancer	0.000555	0.00451	CcSEcCtD
Glimepiride—Hyperhidrosis—Procarbazine—brain cancer	0.000555	0.0045	CcSEcCtD
Glimepiride—KCNJ11—central nervous system—brain cancer	0.000551	0.0384	CbGeAlD
Glimepiride—Anorexia—Procarbazine—brain cancer	0.000547	0.00444	CcSEcCtD
Glimepiride—Erythema—Hydroxyurea—brain cancer	0.000544	0.00442	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00054	0.00438	CcSEcCtD
Glimepiride—KCNJ11—cerebellum—brain cancer	0.000539	0.0376	CbGeAlD
Glimepiride—Nausea—Lomustine—brain cancer	0.000537	0.00436	CcSEcCtD
Glimepiride—Hypotension—Procarbazine—brain cancer	0.000536	0.00435	CcSEcCtD
Glimepiride—Insomnia—Procarbazine—brain cancer	0.000519	0.00421	CcSEcCtD
Glimepiride—Paraesthesia—Procarbazine—brain cancer	0.000515	0.00418	CcSEcCtD
Glimepiride—Somnolence—Procarbazine—brain cancer	0.00051	0.00414	CcSEcCtD
Glimepiride—ABCC8—central nervous system—brain cancer	0.000508	0.0354	CbGeAlD
Glimepiride—Anaemia—Hydroxyurea—brain cancer	0.000503	0.00408	CcSEcCtD
Glimepiride—Decreased appetite—Procarbazine—brain cancer	0.000499	0.00405	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Etoposide—brain cancer	0.000498	0.00404	CcSEcCtD
Glimepiride—ABCC8—cerebellum—brain cancer	0.000496	0.0346	CbGeAlD
Glimepiride—Fatigue—Procarbazine—brain cancer	0.000495	0.00401	CcSEcCtD
Glimepiride—Hepatitis—Temozolomide—brain cancer	0.000489	0.00396	CcSEcCtD
Glimepiride—Leukopenia—Hydroxyurea—brain cancer	0.000487	0.00395	CcSEcCtD
Glimepiride—Visual impairment—Carmustine—brain cancer	0.000487	0.00395	CcSEcCtD
Glimepiride—Sweating increased—Etoposide—brain cancer	0.000476	0.00386	CcSEcCtD
Glimepiride—Feeling abnormal—Procarbazine—brain cancer	0.000473	0.00384	CcSEcCtD
Glimepiride—Convulsion—Hydroxyurea—brain cancer	0.000472	0.00383	CcSEcCtD
Glimepiride—Visual impairment—Temozolomide—brain cancer	0.000471	0.00382	CcSEcCtD
Glimepiride—Gastrointestinal pain—Procarbazine—brain cancer	0.000469	0.00381	CcSEcCtD
Glimepiride—Pancytopenia—Etoposide—brain cancer	0.000464	0.00376	CcSEcCtD
Glimepiride—Erythema multiforme—Temozolomide—brain cancer	0.000462	0.00375	CcSEcCtD
Glimepiride—Urticaria—Procarbazine—brain cancer	0.000456	0.0037	CcSEcCtD
Glimepiride—Abdominal pain—Procarbazine—brain cancer	0.000454	0.00368	CcSEcCtD
Glimepiride—Arrhythmia—Carmustine—brain cancer	0.000452	0.00366	CcSEcCtD
Glimepiride—Erythema—Carmustine—brain cancer	0.00044	0.00357	CcSEcCtD
Glimepiride—Malnutrition—Carmustine—brain cancer	0.00044	0.00357	CcSEcCtD
Glimepiride—KCNJ11—brain—brain cancer	0.000438	0.0305	CbGeAlD
Glimepiride—Thrombocytopenia—Hydroxyurea—brain cancer	0.000435	0.00353	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000432	0.0035	CcSEcCtD
Glimepiride—Erythema—Temozolomide—brain cancer	0.000425	0.00345	CcSEcCtD
Glimepiride—Malnutrition—Temozolomide—brain cancer	0.000425	0.00345	CcSEcCtD
Glimepiride—Jaundice—Etoposide—brain cancer	0.000424	0.00344	CcSEcCtD
Glimepiride—Anorexia—Hydroxyurea—brain cancer	0.000423	0.00343	CcSEcCtD
Glimepiride—Hypersensitivity—Procarbazine—brain cancer	0.000423	0.00343	CcSEcCtD
Glimepiride—Vision blurred—Carmustine—brain cancer	0.000415	0.00336	CcSEcCtD
Glimepiride—Tremor—Carmustine—brain cancer	0.000412	0.00334	CcSEcCtD
Glimepiride—Asthenia—Procarbazine—brain cancer	0.000412	0.00334	CcSEcCtD
Glimepiride—Anaemia—Carmustine—brain cancer	0.000407	0.0033	CcSEcCtD
Glimepiride—Agranulocytosis—Etoposide—brain cancer	0.000406	0.0033	CcSEcCtD
Glimepiride—Pruritus—Procarbazine—brain cancer	0.000406	0.00329	CcSEcCtD
Glimepiride—Agitation—Carmustine—brain cancer	0.000404	0.00328	CcSEcCtD
Glimepiride—ABCC8—brain—brain cancer	0.000403	0.0281	CbGeAlD
Glimepiride—Vision blurred—Temozolomide—brain cancer	0.000401	0.00325	CcSEcCtD
Glimepiride—Tremor—Temozolomide—brain cancer	0.000398	0.00323	CcSEcCtD
Glimepiride—Dyspnoea—Hydroxyurea—brain cancer	0.000396	0.00321	CcSEcCtD
Glimepiride—Somnolence—Hydroxyurea—brain cancer	0.000395	0.0032	CcSEcCtD
Glimepiride—Leukopenia—Carmustine—brain cancer	0.000394	0.00319	CcSEcCtD
Glimepiride—Anaemia—Temozolomide—brain cancer	0.000393	0.00319	CcSEcCtD
Glimepiride—Diarrhoea—Procarbazine—brain cancer	0.000393	0.00319	CcSEcCtD
Glimepiride—Dyspepsia—Hydroxyurea—brain cancer	0.000391	0.00317	CcSEcCtD
Glimepiride—Agitation—Temozolomide—brain cancer	0.000391	0.00317	CcSEcCtD
Glimepiride—Angioedema—Temozolomide—brain cancer	0.000389	0.00315	CcSEcCtD
Glimepiride—Decreased appetite—Hydroxyurea—brain cancer	0.000386	0.00313	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000384	0.00311	CcSEcCtD
Glimepiride—Fatigue—Hydroxyurea—brain cancer	0.000383	0.00311	CcSEcCtD
Glimepiride—Convulsion—Carmustine—brain cancer	0.000381	0.00309	CcSEcCtD
Glimepiride—Leukopenia—Temozolomide—brain cancer	0.000381	0.00309	CcSEcCtD
Glimepiride—Hypertension—Carmustine—brain cancer	0.00038	0.00308	CcSEcCtD
Glimepiride—Dizziness—Procarbazine—brain cancer	0.00038	0.00308	CcSEcCtD
Glimepiride—Palpitations—Temozolomide—brain cancer	0.000376	0.00305	CcSEcCtD
Glimepiride—Anxiety—Carmustine—brain cancer	0.000373	0.00303	CcSEcCtD
Glimepiride—Erythema multiforme—Etoposide—brain cancer	0.00037	0.003	CcSEcCtD
Glimepiride—Convulsion—Temozolomide—brain cancer	0.000368	0.00299	CcSEcCtD
Glimepiride—Hypertension—Temozolomide—brain cancer	0.000367	0.00298	CcSEcCtD
Glimepiride—Feeling abnormal—Hydroxyurea—brain cancer	0.000366	0.00297	CcSEcCtD
Glimepiride—Vomiting—Procarbazine—brain cancer	0.000365	0.00296	CcSEcCtD
Glimepiride—Confusional state—Carmustine—brain cancer	0.000362	0.00294	CcSEcCtD
Glimepiride—Rash—Procarbazine—brain cancer	0.000362	0.00294	CcSEcCtD
Glimepiride—Dermatitis—Procarbazine—brain cancer	0.000362	0.00293	CcSEcCtD
Glimepiride—Anxiety—Temozolomide—brain cancer	0.000361	0.00293	CcSEcCtD
Glimepiride—Headache—Procarbazine—brain cancer	0.00036	0.00292	CcSEcCtD
Glimepiride—Dry mouth—Temozolomide—brain cancer	0.000354	0.00287	CcSEcCtD
Glimepiride—Thrombocytopenia—Carmustine—brain cancer	0.000352	0.00285	CcSEcCtD
Glimepiride—Tachycardia—Carmustine—brain cancer	0.000351	0.00284	CcSEcCtD
Glimepiride—Confusional state—Temozolomide—brain cancer	0.00035	0.00284	CcSEcCtD
Glimepiride—Anaphylactic shock—Temozolomide—brain cancer	0.000347	0.00282	CcSEcCtD
Glimepiride—Anorexia—Carmustine—brain cancer	0.000342	0.00278	CcSEcCtD
Glimepiride—Nausea—Procarbazine—brain cancer	0.000341	0.00277	CcSEcCtD
Glimepiride—Thrombocytopenia—Temozolomide—brain cancer	0.00034	0.00276	CcSEcCtD
Glimepiride—Hypotension—Carmustine—brain cancer	0.000336	0.00272	CcSEcCtD
Glimepiride—Hyperhidrosis—Temozolomide—brain cancer	0.000336	0.00272	CcSEcCtD
Glimepiride—Anorexia—Temozolomide—brain cancer	0.000331	0.00268	CcSEcCtD
Glimepiride—Hypersensitivity—Hydroxyurea—brain cancer	0.000327	0.00265	CcSEcCtD
Glimepiride—Insomnia—Carmustine—brain cancer	0.000325	0.00263	CcSEcCtD
Glimepiride—Paraesthesia—Carmustine—brain cancer	0.000322	0.00262	CcSEcCtD
Glimepiride—Dyspnoea—Carmustine—brain cancer	0.00032	0.0026	CcSEcCtD
Glimepiride—Somnolence—Carmustine—brain cancer	0.000319	0.00259	CcSEcCtD
Glimepiride—Asthenia—Hydroxyurea—brain cancer	0.000319	0.00259	CcSEcCtD
Glimepiride—Anaemia—Etoposide—brain cancer	0.000315	0.00255	CcSEcCtD
Glimepiride—Insomnia—Temozolomide—brain cancer	0.000314	0.00255	CcSEcCtD
Glimepiride—Decreased appetite—Carmustine—brain cancer	0.000312	0.00253	CcSEcCtD
Glimepiride—Paraesthesia—Temozolomide—brain cancer	0.000312	0.00253	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Carmustine—brain cancer	0.00031	0.00251	CcSEcCtD
Glimepiride—Dyspnoea—Temozolomide—brain cancer	0.000309	0.00251	CcSEcCtD
Glimepiride—Somnolence—Temozolomide—brain cancer	0.000309	0.0025	CcSEcCtD
Glimepiride—Dyspepsia—Temozolomide—brain cancer	0.000306	0.00248	CcSEcCtD
Glimepiride—Leukopenia—Etoposide—brain cancer	0.000305	0.00247	CcSEcCtD
Glimepiride—Diarrhoea—Hydroxyurea—brain cancer	0.000304	0.00247	CcSEcCtD
Glimepiride—Decreased appetite—Temozolomide—brain cancer	0.000302	0.00245	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Temozolomide—brain cancer	0.0003	0.00243	CcSEcCtD
Glimepiride—Fatigue—Temozolomide—brain cancer	0.000299	0.00243	CcSEcCtD
Glimepiride—Loss of consciousness—Etoposide—brain cancer	0.000299	0.00243	CcSEcCtD
Glimepiride—Feeling abnormal—Carmustine—brain cancer	0.000296	0.0024	CcSEcCtD
Glimepiride—Convulsion—Etoposide—brain cancer	0.000295	0.00239	CcSEcCtD
Glimepiride—Hypertension—Etoposide—brain cancer	0.000294	0.00238	CcSEcCtD
Glimepiride—Dizziness—Hydroxyurea—brain cancer	0.000294	0.00238	CcSEcCtD
Glimepiride—Gastrointestinal pain—Carmustine—brain cancer	0.000294	0.00238	CcSEcCtD
Glimepiride—Feeling abnormal—Temozolomide—brain cancer	0.000286	0.00232	CcSEcCtD
Glimepiride—Abdominal pain—Carmustine—brain cancer	0.000284	0.0023	CcSEcCtD
Glimepiride—Gastrointestinal pain—Temozolomide—brain cancer	0.000284	0.0023	CcSEcCtD
Glimepiride—Vomiting—Hydroxyurea—brain cancer	0.000282	0.00229	CcSEcCtD
Glimepiride—Rash—Hydroxyurea—brain cancer	0.00028	0.00227	CcSEcCtD
Glimepiride—Confusional state—Etoposide—brain cancer	0.00028	0.00227	CcSEcCtD
Glimepiride—Dermatitis—Hydroxyurea—brain cancer	0.00028	0.00227	CcSEcCtD
Glimepiride—Headache—Hydroxyurea—brain cancer	0.000278	0.00226	CcSEcCtD
Glimepiride—Anaphylactic shock—Etoposide—brain cancer	0.000278	0.00225	CcSEcCtD
Glimepiride—Urticaria—Temozolomide—brain cancer	0.000276	0.00224	CcSEcCtD
Glimepiride—Abdominal pain—Temozolomide—brain cancer	0.000274	0.00223	CcSEcCtD
Glimepiride—Thrombocytopenia—Etoposide—brain cancer	0.000272	0.00221	CcSEcCtD
Glimepiride—Tachycardia—Etoposide—brain cancer	0.000271	0.0022	CcSEcCtD
Glimepiride—Hyperhidrosis—Etoposide—brain cancer	0.000268	0.00218	CcSEcCtD
Glimepiride—Anorexia—Etoposide—brain cancer	0.000265	0.00215	CcSEcCtD
Glimepiride—Hypersensitivity—Carmustine—brain cancer	0.000265	0.00215	CcSEcCtD
Glimepiride—Nausea—Hydroxyurea—brain cancer	0.000264	0.00214	CcSEcCtD
Glimepiride—Hypotension—Etoposide—brain cancer	0.00026	0.0021	CcSEcCtD
Glimepiride—Asthenia—Carmustine—brain cancer	0.000258	0.00209	CcSEcCtD
Glimepiride—Hypersensitivity—Temozolomide—brain cancer	0.000256	0.00207	CcSEcCtD
Glimepiride—CYP2C9—endocrine gland—brain cancer	0.000252	0.0176	CbGeAlD
Glimepiride—Paraesthesia—Etoposide—brain cancer	0.000249	0.00202	CcSEcCtD
Glimepiride—Asthenia—Temozolomide—brain cancer	0.000249	0.00202	CcSEcCtD
Glimepiride—Dyspnoea—Etoposide—brain cancer	0.000248	0.00201	CcSEcCtD
Glimepiride—Somnolence—Etoposide—brain cancer	0.000247	0.002	CcSEcCtD
Glimepiride—Diarrhoea—Carmustine—brain cancer	0.000246	0.00199	CcSEcCtD
Glimepiride—Pruritus—Temozolomide—brain cancer	0.000246	0.00199	CcSEcCtD
Glimepiride—Decreased appetite—Etoposide—brain cancer	0.000241	0.00196	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Etoposide—brain cancer	0.00024	0.00194	CcSEcCtD
Glimepiride—Fatigue—Etoposide—brain cancer	0.000239	0.00194	CcSEcCtD
Glimepiride—Dizziness—Carmustine—brain cancer	0.000237	0.00193	CcSEcCtD
Glimepiride—Diarrhoea—Temozolomide—brain cancer	0.000237	0.00193	CcSEcCtD
Glimepiride—Dizziness—Temozolomide—brain cancer	0.00023	0.00186	CcSEcCtD
Glimepiride—Feeling abnormal—Etoposide—brain cancer	0.000229	0.00186	CcSEcCtD
Glimepiride—Vomiting—Carmustine—brain cancer	0.000228	0.00185	CcSEcCtD
Glimepiride—Gastrointestinal pain—Etoposide—brain cancer	0.000227	0.00184	CcSEcCtD
Glimepiride—Rash—Carmustine—brain cancer	0.000226	0.00184	CcSEcCtD
Glimepiride—Dermatitis—Carmustine—brain cancer	0.000226	0.00184	CcSEcCtD
Glimepiride—Headache—Carmustine—brain cancer	0.000225	0.00182	CcSEcCtD
Glimepiride—Vomiting—Temozolomide—brain cancer	0.000221	0.00179	CcSEcCtD
Glimepiride—Urticaria—Etoposide—brain cancer	0.000221	0.00179	CcSEcCtD
Glimepiride—Abdominal pain—Etoposide—brain cancer	0.00022	0.00178	CcSEcCtD
Glimepiride—Rash—Temozolomide—brain cancer	0.000219	0.00177	CcSEcCtD
Glimepiride—Dermatitis—Temozolomide—brain cancer	0.000219	0.00177	CcSEcCtD
Glimepiride—Headache—Temozolomide—brain cancer	0.000217	0.00176	CcSEcCtD
Glimepiride—Nausea—Carmustine—brain cancer	0.000213	0.00173	CcSEcCtD
Glimepiride—Nausea—Temozolomide—brain cancer	0.000206	0.00167	CcSEcCtD
Glimepiride—Hypersensitivity—Etoposide—brain cancer	0.000205	0.00166	CcSEcCtD
Glimepiride—Asthenia—Etoposide—brain cancer	0.000199	0.00162	CcSEcCtD
Glimepiride—Pruritus—Etoposide—brain cancer	0.000196	0.00159	CcSEcCtD
Glimepiride—Diarrhoea—Etoposide—brain cancer	0.00019	0.00154	CcSEcCtD
Glimepiride—Dizziness—Etoposide—brain cancer	0.000184	0.00149	CcSEcCtD
Glimepiride—Vomiting—Etoposide—brain cancer	0.000177	0.00143	CcSEcCtD
Glimepiride—Rash—Etoposide—brain cancer	0.000175	0.00142	CcSEcCtD
Glimepiride—Dermatitis—Etoposide—brain cancer	0.000175	0.00142	CcSEcCtD
Glimepiride—Headache—Etoposide—brain cancer	0.000174	0.00141	CcSEcCtD
Glimepiride—Nausea—Etoposide—brain cancer	0.000165	0.00134	CcSEcCtD
